1995
DOI: 10.1016/0378-4274(95)03357-q
|View full text |Cite
|
Sign up to set email alerts
|

Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(13 citation statements)
references
References 98 publications
0
13
0
Order By: Relevance
“…PBPK models have been developed for use in toxicity risk assessment for a variety of chemicals and some chemical mixtures (Leung & Paustenbach, 1995;Simmons, 1996). Models that yield simulations consistent with experimental data in one species can be used to extrapolate to other species, dose regimens, or routes of administration (Clewell & Andersen, 1985;Dallas et al, 1995).…”
mentioning
confidence: 99%
“…PBPK models have been developed for use in toxicity risk assessment for a variety of chemicals and some chemical mixtures (Leung & Paustenbach, 1995;Simmons, 1996). Models that yield simulations consistent with experimental data in one species can be used to extrapolate to other species, dose regimens, or routes of administration (Clewell & Andersen, 1985;Dallas et al, 1995).…”
mentioning
confidence: 99%
“…Today, the risk assessment community uses PBPK models as an important tool for improving the accuracy of human health risk assessments for hazardous substances (Clewell, 1995;Leung and Paustenbach, 1995;Wilson et al, 2002). The ultimate aim of using PBPK modeling in risk assessment is to provide a measure of dose which better represents the biologically eVective dose-that is, the dose which causally relates to the toxic outcome.…”
Section: Use Of Pbpk Modeling In Chemical Risk Assessmentmentioning
confidence: 98%
“…To enable extrapolation, physiologically based pharmacokinetic (PBPK) models have emerged as an important tool that has seen broad applications in toxicology and more specifically in human health risk assessment (Andersen, 1995;Clewell and Andersen, 1996;Krishnan and Andersen, 2001;Leung and Paustenbach, 1995;Mason and Wilson, 1999). Their potential utility as a modeling tool for biological monitoring has only recently been explored (Garabrant et al, 2008;Tan et al, 2007).…”
Section: Compartmental Pharmacokinetic Modelsmentioning
confidence: 99%
“…PBPK models have been developed to describe target tissue dosimetry for a broad range of environmental contaminants, such as solvents, heavy metals, and pesticides, including organophosphate and carbamate insecticides (Andersen et al, 1987;Corley et al, 1990;Gearhart et al, 1990;Nong et al, 2008;Poet et al, 2004;Sultatos, 1990;Timchalk et al, 2002). A number of reviews have been published on the development, validation, application, and limitations of PBPK models in human health risk assessment (Andersen, 1995(Andersen, , 2003Clewell, 1995;Clewell and Andersen, 1996;Frederick, 1995;Krishnan and Andersen, 2001;Leung and Paustenbach, 1995;Mason and Wilson, 1999).…”
Section: Physiologically Based Pharmacokinetic Modelsmentioning
confidence: 99%